Apontis Pharma AG
XETRA:APPH
Intrinsic Value
The intrinsic value of one APPH stock under the Base Case scenario is hidden EUR. Compared to the current market price of 11.35 EUR, Apontis Pharma AG is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Apontis Pharma AG
Fundamental Analysis

Revenue & Expenses Breakdown
Apontis Pharma AG
Balance Sheet Decomposition
Apontis Pharma AG
Current Assets | 23.4m |
Cash & Short-Term Investments | 14.3m |
Receivables | 2.7m |
Other Current Assets | 6.4m |
Non-Current Assets | 22m |
Other Non-Current Assets | 22m |
Free Cash Flow Analysis
Apontis Pharma AG
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Apontis Pharma AG
Revenue
|
63.8m
EUR
|
Cost of Revenue
|
-25.4m
EUR
|
Gross Profit
|
38.5m
EUR
|
Operating Expenses
|
-47.1m
EUR
|
Operating Income
|
-8.7m
EUR
|
Other Expenses
|
2.1m
EUR
|
Net Income
|
-6.6m
EUR
|
APPH Profitability Score
Profitability Due Diligence
Apontis Pharma AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Apontis Pharma AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.
APPH Solvency Score
Solvency Due Diligence
Apontis Pharma AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Apontis Pharma AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APPH Price Targets Summary
Apontis Pharma AG
According to Wall Street analysts, the average 1-year price target for APPH is 14.62 EUR with a low forecast of 10.1 EUR and a high forecast of 17.85 EUR.
Dividends
Current shareholder yield for APPH is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one APPH stock under the Base Case scenario is hidden EUR.
Compared to the current market price of 11.35 EUR, Apontis Pharma AG is hidden .